'Tomudex' (raltitrexed) plus 5-fluorouracil: A promising option for the treatment of patients with metastatic colorectal cancer

被引：1
|
作者：
Schwartz, GK
Bertino, J
Kemeny, N
Saltz, L
Kelsen, DK
Tong, W
Barazzuol, J
Lowery, C
Smith, M
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Zeneca Pharmaceut, Wilmington, DE USA
[3] Zeneca Pharmaceut, Alderley Pk, England
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80666-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
233
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [1] An economic evaluation of Tomudex (raltitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancer
    Groener, MGH
    van Ineveld, BM
    Byttebier, G
    van Hout, BA
    Rutten, FFH
    ANTI-CANCER DRUGS, 1999, 10 (03) : 283 - 288
  • [2] Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity
    C-H Köhne
    P Thuss-Patience
    M Friedrich
    PT Daniel
    A Kretzschmar
    T Benter
    B Bauer
    R Dietz
    B Dörken
    British Journal of Cancer, 1998, 77 : 973 - 977
  • [3] Raltitrexed (Tomudex):: an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity
    Köhne, CH
    Thuss-Patience, P
    Friedrich, M
    Daniel, PT
    Kretzschmar, A
    Benter, T
    Bauer, B
    Dietz, R
    Dörken, B
    BRITISH JOURNAL OF CANCER, 1998, 77 (06) : 973 - 977
  • [4] Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy
    Nicolas Tsavaris
    Christos Kosmas
    Maria Vadiaka
    Christos Koufos
    BMC Cancer, 2
  • [5] Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy
    Tsavaris, N
    Kosmas, C
    Vadiaka, M
    Koufos, C
    BMC CANCER, 2002, 2 (1)
  • [6] Raltitrexed (Tomudex®):: An alternative choice in patients intolerant to 5-fluorouracil
    Kempin, S
    Gutierrez, J
    Wilson, E
    Lowery, C
    Diasio, R
    CANCER INVESTIGATION, 2002, 20 (7-8) : 992 - 995
  • [7] Final results of a randomised trial comparing 'Tomudex'(R) (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer
    Cunningham, D
    Zalcberg, JR
    Rath, U
    Oliver, I
    vanCutsem, E
    Svensson, C
    Seitz, JF
    Harper, P
    Kerr, D
    PerezManga, G
    ANNALS OF ONCOLOGY, 1996, 7 (09) : 961 - 965
  • [8] Raltitrexed (Tomudex™) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer:: Preliminary results from phase I clinical trials
    Schwartz, GK
    Harstrick, A
    Barón, MG
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S9 - S13
  • [9] Efficacy of infusional biomodulated 5-fluorouracil in metastatic colorectal cancer after raltitrexed failure
    Decoster, L
    Neyns, B
    Akouaouach, H
    Fontaine, C
    Schallier, D
    De Gréve, JLP
    ANTICANCER RESEARCH, 2004, 24 (3B) : 2037 - 2040
  • [10] Cardiac outcomes of raltitrexed in the treatment of colorectal cancer patients with 5-fluorouracil (5-FU) cardiotoxicity
    Firouzbakht, Aryan
    Renouf, Daniel John
    Chen, Leo
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345